# Controlled Attenuation Parameter (CAP) in Liver Allografts

> **NCT02798861** · — · COMPLETED · sponsor: **Andres Duarte-Rojo** · enrollment: 160 (actual)

## Conditions studied

- Liver Transplant
- Liver Steatosis
- Liver Disease
- Primary Non-function
- Early Allograft Dysfunction

## Interventions

- **DEVICE:** Fibroscan 402/530

## Key facts

- **NCT ID:** NCT02798861
- **Lead sponsor:** Andres Duarte-Rojo
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09-07
- **Primary completion:** 2019-06-01
- **Final completion:** 2019-06-01
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2020-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02798861

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02798861, "Controlled Attenuation Parameter (CAP) in Liver Allografts". Retrieved via AI Analytics 2026-07-30 from https://api.ai-analytics.org/clinical/NCT02798861. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*